Growth Metrics

Rockwell Medical (RMTI) Enterprise Value (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Enterprise Value for 16 consecutive years, with -$23.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Enterprise Value fell 29.74% year-over-year to -$23.7 million, compared with a TTM value of -$23.7 million through Sep 2025, down 29.74%, and an annual FY2024 reading of -$21.6 million, down 97.55% over the prior year.
  • Enterprise Value was -$23.7 million for Q3 2025 at Rockwell Medical, down from -$18.4 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$8.6 million in Q1 2024 and bottomed at -$46.1 million in Q1 2021.
  • Average Enterprise Value over 5 years is -$21.4 million, with a median of -$18.4 million recorded in 2025.
  • The sharpest move saw Enterprise Value surged 78.54% in 2022, then crashed 101.08% in 2025.
  • Year by year, Enterprise Value stood at -$22.4 million in 2021, then rose by 4.22% to -$21.5 million in 2022, then soared by 49.12% to -$10.9 million in 2023, then crashed by 97.55% to -$21.6 million in 2024, then dropped by 9.74% to -$23.7 million in 2025.
  • Business Quant data shows Enterprise Value for RMTI at -$23.7 million in Q3 2025, -$18.4 million in Q2 2025, and -$17.3 million in Q1 2025.